Official recall notice

FDA DrugClass IINotable

FDA Recall: Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc.,

Recall date
2026-09-23
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).

Product description

Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).

Affected products

Lot # AD48154, Exp: 4/30/2027.

Verify with the official notice →
Share:

Related Recalls

2026-10-01 · FDA_DRUG
FDA Recall: Greewich: Glutathione Injection
Greewich
2026-09-23 · FDA_DRUG
FDA Recall: Fluphenazine HCl Elixir, USP, 5 mg per 10 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volu
Safecor Health, LLC
2026-09-23 · FDA_DRUG
FDA Recall: Fluphenazine HCl Elixir, USP, 15 mg per 3 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volu
Safecor Health, LLC
2026-09-23 · FDA_DRUG
FDA Recall: Fluphenazine HCl Elixir, USP, 20 mg per 4 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volu
Safecor Health, LLC